Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization

Table 1 Demographic, clinical, histological and laboratory characteristics of patients n (%)

Characteristics	Group A, n	Group B	P-value
Patients	26	24
Sex
Male	19 (73)	18 (75)	0.8771
Female	7 (27)	6 (25)
Age (yr)	44.1 ± 12.1	45.0 ± 9.0	0 .7602
Child-Pugh grade
A	2 (8)	2 (8)
B	20 (77)	19 (79)	0.8061
C	4 (15)	3 (13)
Pathology type
Mass type	14 (54)	14 (58)	0.8341
Node type	10 (38)	8 (33)
Diffusion type	2 (8)	2 (8)
Tumor diameter (cm)
Peripheral blood cell counts	4.64 ± 2.34	4.44 ± 2.58	0.7802
WBC (× 109)	2.45 ± 0.41	2.40 ± 0.51	0.7342
PLT (× 109)	45.95 ± 9.49	45.02 ± 8.96	0.7232
RBC (× 1012)	3.02 ± 0.49	3.07 ± 0.51	0.7502

¹Data are determined with the χ² test;

²Data are determined with the t-test.